Lymphoma, Large-Cell, Immunoblastic, also known as lymphoma large cell immunoblastic, is related to peripheral t-cell lymphoma and reticulosarcoma. An important gene associated with Lymphoma, Large-Cell, Immunoblastic is MYC (MYC Proto-Oncogene, BHLH Transcription Factor), and among its related pathways/superpathways are Overview of interferons-mediated signaling pathway and Immune response IL-23 signaling pathway. The drugs Rituximab and Etoposide have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and t cells.